Cabot Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Cabot de 57.8% y 3.7% por año respectivamente. Se prevé que el BPA crezca en un 58.9% al año. Se espera que la rentabilidad financiera sea de 21.2% en 3 años.
Información clave
57.8%
Tasa de crecimiento de los beneficios
58.88%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Chemicals | 21.6% |
| Tasa de crecimiento de los ingresos | 3.7% |
| Rentabilidad financiera futura | 21.18% |
| Cobertura de analistas | Good |
| Última actualización | 23 Aug 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • Aug 16
CBT: Rising Carbon Black Concerns Will Drive A Weaker Future Profile
Cabot's analyst price target has moved up from $70.37 to $78.00, with analysts pointing to updated views on revenue growth, profitability, and P/E assumptions following recent research that includes higher price objectives of $90 and $100, along with positive commentary on the battery materials and Performance Chemicals businesses. Analyst Commentary Recent research on Cabot has centered on how the stock trades relative to its P/E assumptions and perceived growth potential in key businesses such as battery materials and Performance Chemicals.Seeking Alpha • Aug 04
Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)
Summary Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT’s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures. Future growth hinges on recovery in reinforcement materials and continued strength in performance chemicals, but macro risks constrain further upside. Read the full article on Seeking AlphaNueva narrativa • Aug 02
Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential
Catalysts About Cabot Cabot Corporation produces specialty chemicals and materials including reinforcement materials, performance chemicals and battery materials that serve a range of industrial and energy storage applications. What are the underlying business or industry changes driving this perspective?
Actualización de narrativa • Jun 26
CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook
Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
Nueva narrativa • Jun 23
Battery And Data Center Demand Will Drive Long-Term Upside Potential
Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?Artículo de análisis • Jun 21
Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating
Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...Nueva narrativa • Jun 09
Battery And Data Center Demand Will Support A Steady Long Term Materials Story
Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?Artículo de análisis • Nov 03
Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?
While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...Artículo de análisis • Sep 11
Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch
With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...Artículo de análisis • Jul 20
Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?
Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...Artículo de análisis • Jun 23
Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Artículo de análisis • Apr 25
These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Apr 10
Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price
Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...Artículo de análisis • Mar 12
A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price
Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...Seeking Alpha • Feb 13
Cabot Corporation: Reinforcing Positive Shareholder Value
Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking AlphaSeeking Alpha • Jan 30
Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)
Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking AlphaArtículo de análisis • Jan 29
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...Artículo de análisis • Jan 15
Is Cabot (NYSE:CBT) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Jan 02
Returns On Capital Are A Standout For Cabot (NYSE:CBT)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Artículo de análisis • Dec 06
Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...Seeking Alpha • Nov 14
Cabot: Less Than 5% Annualized Upside
Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking AlphaArtículo de análisis • Oct 31
Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Artículo de análisis • Oct 19
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2028 | 3,923 | N/A | 261 | 551 | 5 |
| 9/30/2027 | 3,796 | 378 | 252 | 517 | 6 |
| 9/30/2026 | 3,683 | 226 | 203 | 443 | 6 |
| 6/30/2026 | 3,634 | 187 | 281 | 497 | N/A |
| 3/31/2026 | 3,575 | 281 | 432 | 671 | N/A |
| 12/31/2025 | 3,607 | 306 | 401 | 667 | N/A |
| 9/30/2025 | 3,713 | 326 | 364 | 665 | N/A |
| 6/30/2025 | 3,815 | 418 | 321 | 650 | N/A |
| 3/31/2025 | 3,908 | 426 | 288 | 608 | N/A |
| 12/31/2024 | 3,991 | 417 | 420 | 711 | N/A |
| 9/30/2024 | 3,994 | 374 | 451 | 692 | N/A |
| 6/30/2024 | 3,958 | 470 | 399 | 626 | N/A |
| 3/31/2024 | 3,910 | 443 | 407 | 662 | N/A |
| 12/31/2023 | 3,924 | 433 | 385 | 648 | N/A |
| 9/30/2023 | 3,931 | 437 | 351 | 595 | N/A |
| 6/30/2023 | 4,078 | 300 | 306 | 562 | N/A |
| 3/31/2023 | 4,259 | 315 | 127 | 353 | N/A |
| 12/31/2022 | 4,318 | 348 | -15 | 201 | N/A |
| 9/30/2022 | 4,321 | 206 | -111 | 100 | N/A |
| 6/30/2022 | 4,113 | 142 | -106 | 95 | N/A |
| 3/31/2022 | 3,881 | 130 | -65 | 132 | N/A |
| 12/31/2021 | 3,631 | 98 | -9 | 187 | N/A |
| 9/30/2021 | 3,409 | 247 | 62 | 257 | N/A |
| 6/30/2021 | 3,164 | -54 | 103 | 256 | N/A |
| 3/31/2021 | 2,765 | -144 | 184 | 334 | N/A |
| 12/31/2020 | 2,633 | -219 | 132 | 293 | N/A |
| 9/30/2020 | 2,614 | -238 | 177 | 377 | N/A |
| 6/30/2020 | 2,782 | 65 | 244 | 475 | N/A |
| 3/31/2020 | 3,109 | 103 | N/A | 441 | N/A |
| 12/31/2019 | 3,243 | 127 | N/A | 507 | N/A |
| 9/30/2019 | 3,337 | 155 | N/A | 363 | N/A |
| 6/30/2019 | 3,360 | 217 | N/A | 321 | N/A |
| 3/31/2019 | 3,369 | 273 | N/A | 268 | N/A |
| 12/31/2018 | 3,343 | 77 | N/A | 214 | N/A |
| 9/30/2018 | 3,242 | -114 | N/A | 298 | N/A |
| 6/30/2018 | 3,115 | -136 | N/A | 300 | N/A |
| 3/31/2018 | 2,966 | -177 | N/A | 371 | N/A |
| 12/31/2017 | 2,826 | 69 | N/A | 286 | N/A |
| 9/30/2017 | 2,717 | 246 | N/A | 348 | N/A |
| 6/30/2017 | 2,613 | 225 | N/A | 288 | N/A |
| 3/31/2017 | 2,529 | 234 | N/A | 262 | N/A |
| 12/31/2016 | 2,419 | 209 | N/A | 416 | N/A |
| 9/30/2016 | 2,411 | 145 | N/A | 392 | N/A |
| 6/30/2016 | 2,463 | 136 | N/A | 516 | N/A |
| 3/31/2016 | 2,536 | -366 | N/A | 482 | N/A |
| 12/31/2015 | 2,662 | -388 | N/A | 526 | N/A |
| 9/30/2015 | 2,871 | -336 | N/A | 499 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (57.8% al año) de CBT es superior a la tasa de ahorro (3.7%).
Beneficios vs. Mercado: Se prevé que los beneficios (57.8% al año) de CBT crezcan más rápidamente que el mercado US (17.1% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de CBT crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (3.7% al año) de CBT crezcan más despacio que el mercado de US (13.3% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 3.7% al año) de CBT crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CBT sea alta dentro de 3 años (21.2%)
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/09/15 18:13 |
| Precio de las acciones al final del día | 2026/09/15 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/09/30 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Cabot Corporation está cubierta por 11 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Benjamin Kallo | Baird |
| Michael Leithead | Barclays |
| David Begleiter | Deutsche Bank |